ReviewSignal transduction and targeted therapy2023
CRISPR/Cas9 therapeutics: progress and prospects.
Tianxiang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
339 papers cite itlatest 60 shown
this paperpooled itcites it
ReviewSignal transduction and targeted therapy2023
Tianxiang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.